FDA grants fast track status to Prestige’s PBP1510 for pancreatic cancer

PBP1510 will mainly act on a tumour-specific protein called pancreatic adenocarcinoma upregulated factor. Credit: National Cancer Institute on Unsplash.



  • Prestige Biopharma